Independent GLP-1 research
Understand the treatment. Compare the program. Know what you’re paying for.
Evidence-conscious guides to GLP-1 telehealth, provider pricing, compounded-product distinctions and the questions worth asking before you enroll.
The HealthRX button is an affiliate link. We may earn a commission. Prescription approval is never guaranteed.
Research by intent
Semaglutide
Semaglutide research
Semaglutide education, provider research and compounded-product distinctions.
Tirzepatide
Tirzepatide research
Tirzepatide education, provider research and compounded-product distinctions.
A regulatory distinction that matters: compounded medications are not FDA-approved and do not undergo FDA premarket review for safety, quality or effectiveness. GLP Guidebook clearly labels compounded-program coverage and links to primary sources.
Built in four publishing waves
Wave 1 captures the highest-value HealthRX, provider, cost and medication-comparison intents. Waves 2–4 expand into clinical-process literacy, pricing mechanics, product-status questions and practical telehealth decision support without drifting into generic weight-loss content.